References
- PatelTIncreasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United StatesHepatology2001336v13531357
- ShaibYHDavilaJAMcGlynnKEl-SeragHBRising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?J Hepatol200440347247715123362
- McGlynnKATaroneREEl-SeragHBA comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United StatesCancer Epidemiol Biomarkers Prev20061561198120316775181
- EndoIGonenMYoppACIntrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resectionAnn Surg20082481849618580211
- ChouFFSheen-ChenSMChenYSSurgical treatment of cholangiocarcinomaHepatogastroenterology1997447607659222685
- ShinoharaETMitraNGuoMMetzJMRadiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinomaInt J Radiat Oncol Biol Phys2008721495150118472359
- ValleJWasanHPalmerDHCisplatin plus gemcitabine versus gemcitabine for biliary tract cancerN Engl J Med20103621273128120375404
- TaoRKrishnanSBhosalePRAblative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysisJ Clin Oncol201634321922626503201
- ChenYXZengZCTangZYDetermining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patientsBMC Cancer20101049220840777
- JacksonMWAminiAJonesBLRusthovenCGSchefterTEGoodmanKATreatment selection and survival outcomes with and without radiation for unresectable, localized intrahepatic cholangiocarcinomaCancer J201622423724227441741
- AminiNEjazASpolveratoGKimYHermanJMPawlikTMTemporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysisJ Surg Oncol2014110216317024676600
- FritzAPercyCJackAInternational Classification of Diseases for OncologyGeneva, SwitzerlandWorld Health Organization2000
- JoffeMMRosenbaumPRInvited commentary: propensity scoresAm J Epidemiol1999150432733310453808
- AustinPCAn introduction to propensity score methods for reducing the effects of confounding in observational studiesMultivariate Behav Res201146339942421818162
- IshwaranHKogalurUBBlackstoneEHLauerMSRandom survival forestsAnn Appl Stat200823841860
- HoDEImaiKKingGStuartEAMatching as nonparametric preprocessing for reducing model dependence in parametric causal inferencePolit Anal200715199236
- van der VeldenJvan LindertACGimbrereCHOostingHHeintzAPEpidemiologic data on vulvar cancer: comparison of hospital with population-based dataGynecol Oncol19966233793838812536
- GoodmanKAWiegnerEAMaturenKEDose-escalation study of single-fraction stereotactic body radiotherapy for liver malignanciesInt J Radiat Oncol Biol Phys201078248649320350791
- BarneyBMOlivierKRMillerRCHaddockMGClinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinomaRadiat Oncol201276722553982
- TseRVHawkinsMLockwoodGPhase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinomaJ Clin Oncol200826465766418172187
- MahadevanADagogluNManciasJStereotactic body radiotherapy (SBRT) for intrahepatic and hilar cholangiocarcinomaJ Cancer20156111099110426516357
- HongTSWoJYYeapBYMulti-institutional phase II study of highdose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinomaJ Clin Oncol201634546046826668346